ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Activity
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

58 hedge funds and large institutions have $17.8M invested in Oncternal Therapeutics, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 16 closing their positions.

Holders
58
Holders Change
-5
Holders Change %
-7.94%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
19
Reduced
14
Closed
16
Calls
$1.71M
Puts
$1.77M
Net Calls
-$58K
Net Calls Change
-$5.67M

Top Buyers

1
AQR Capital Management
1
AQR Capital Management
Connecticut
$904K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$490K
3
BFA
3
BlackRock Fund Advisors
California
$2.9M
4
Ameriprise
4
Ameriprise
Minnesota
$307K
5
TC
5
TFS Capital
Pennsylvania
$222K

Top Sellers

1
PC
1
PointState Capital
New York
$0
2
OIM
2
Oracle Investment Management
Connecticut
$1.75M
3
CII
3
CR Intrinsic Investors
Connecticut
$0
4
VAM
4
Visium Asset Management
New York
$0
5
JG
5
Jefferies Group
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
RFC
76
Russell Frank Company
Washington
– -$1K – –
1 2 3
4